Clinical Trial: Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867379) titled 'Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia' on Oct. 05.

Brief Summary: This single-blind randomized controlled trial aims to compare the therapeutic effects of Botulinum Toxin Type A and triamcinolone injections in adults with facial myofascial pain syndrome. A total of 56 participants will be randomly allocated in a 1:1 ratio to receive either Botulinum Toxin Type A or triamcinolone injection. The primary outcome will assess pain intensity using the Visual Analogue Scale (VAS). Secondary outcomes will evaluate headache symptoms and sleep quality. The study aims to determine the comparative effectiveness of the t...